Recent identification of mutations in SAMHD1 in various cancer cell types generated a unique opportunity to understand the role of dNTP hydrolysis and its regulation in the elevated intracellular dNTP pools observed in cancer cells. The gene discussed is SAMHD1; the disease is cancer.